Cambridge, MA – Evelo Therapeutics, a biotech company pioneering the development of microbiome-based therapies for cancer, recently announced the official opening of its new 9,000 square foot headquarters in Cambridge, Massachusetts. The company emerged from Flagship VentureLabs®, the innovation foundry of Flagship Ventures, with an initial capital commitment of $35 million in November 2015. The ribbon-cutting ceremony will be held today at 4pm in collaboration with the Massachusetts Life Sciences Center (MLSC) and MassBio.
“I congratulate Evelo Therapeutics on their expansion and look forward to their continued contributions to job creation and innovation here in the Commonwealth,” said Governor Charlie Baker.
“We are extremely pleased with our new facility and the opportunity that it affords Evelo during this important growth period,” said Dr. Simba Gill, CEO of Evelo. “Cambridge is the undisputed hub of great biotech companies and we are excited to contribute to its legacy of innovative science and transformative medicine.”
The 9,000 square foot headquarters features a state-of-the-art laboratory space and office designed to foster collaboration. At this site, Evelo will continue to advance its research platform, based on a deep understanding of the cancer microbiome, and develop its Oncobiotic™ therapeutics as a new modality in cancer treatment.
“We are pleased to celebrate the grand opening of Evelo’s new headquarters in Cambridge,” said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. “This new facility will allow the company to continue to grow and make important contributions to cancer therapeutics, one of the core strengths of our Commonwealth’s life sciences ecosystem.”
“We congratulate MassBio member Evelo Therapeutics on the grand opening of their exciting new headquarters in Cambridge, MA,” said Robert K. Coughlin, President & CEO of MassBio. “We are thrilled to see Evelo Therapeutics’ growth and know they will continue to thrive in Massachusetts’ robust oncology research and development community.”
Evelo Therapeutics is located at 620 Memorial Drive, Suite 200 West, Cambridge, MA 02139.
